MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 158 filers reported holding MERSANA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,193,125 | -29.9% | 290,298 | 0.0% | 0.04% | -36.9% |
| Q4 2022 | $1,701,146 | -13.3% | 290,298 | 0.0% | 0.06% | -20.7% |
| Q3 2022 | $1,962,000 | -14.3% | 290,298 | -41.4% | 0.08% | -5.7% |
| Q2 2022 | $2,289,000 | +15.8% | 495,481 | 0.0% | 0.09% | +42.6% |
| Q1 2022 | $1,977,000 | -35.9% | 495,481 | 0.0% | 0.06% | -29.1% |
| Q4 2021 | $3,082,000 | +194.6% | 495,481 | +346.8% | 0.09% | +196.6% |
| Q3 2021 | $1,046,000 | -30.5% | 110,906 | 0.0% | 0.03% | -17.1% |
| Q2 2021 | $1,506,000 | -16.1% | 110,906 | 0.0% | 0.04% | -12.5% |
| Q1 2021 | $1,794,000 | -39.2% | 110,906 | 0.0% | 0.04% | -41.2% |
| Q4 2020 | $2,951,000 | +42.9% | 110,906 | 0.0% | 0.07% | +33.3% |
| Q3 2020 | $2,065,000 | -20.4% | 110,906 | 0.0% | 0.05% | -13.6% |
| Q2 2020 | $2,595,000 | – | 110,906 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
| Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
| Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
| Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
| Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
| DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |